Nuts and their bioactive constituents:: effects on serum lipids and other factors that affect disease risk

被引:0
|
作者
Kris-Etherton, PM
Yu-Poth, S
Sabaté, J
Ratcliffe, HE
Zhao, GX
Etherton, TD
机构
[1] Penn State Univ, Dept Nutr, Grad Program Nutr, University Pk, PA 16802 USA
[2] Penn State Univ, Dept Dairy & Anim Sci, University Pk, PA 16802 USA
[3] Loma Linda Univ, Sch Publ Hlth, Dept Nutr, Loma Linda, CA 92350 USA
关键词
nuts; plant foods; dietary fat; saturated fatty acids; monounsaturated fatty acids; polyunsaturated fatty acids; predictive equations; coronary heart disease risk reduction; cardiovascular disease prevention; blood cholesterol; LDL cholesterol; phytochemicals; plant sterols; dietary fiber; copper; magnesium;
D O I
暂无
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Because nuts have favorable fatty acid and nutrient profiles, there is growing interest in evaluating their role in a heart-healthy diet. Nuts are low in saturated fatty acids and high in monounsaturated and polyunsaturated fatty acids. In addition, emerging evidence indicates that there are other bioactive molecules in nuts that elicit cardioprotective effects. These include plant protein, dietary fiber, micronutrients such as copper and magnesium, plant sterols, and phytochemicals. Few feeding studies have been conducted that have incorporated different nuts into the test diets to determine the effects on plasma lipids and Lipoproteins. The total- and lipoprotein-cholesterol responses to these diets are summarized in this article. In addition, the actual cholesterol response was compared with the predicted response derived from the most current predictive equations for blood cholesterol. Results from this comparison showed that when subjects consumed test diets including nuts, there was an approximate to 25% greater cholesterol-lowering response than that predicted by the equations. These results suggest that there are non-fatty acid constituents in nuts that have additional cholesterol-lowering effects. Further studies are needed to identify these constituents and establish their relative cholesterol-lowering potency.
引用
收藏
页码:504S / 511S
页数:8
相关论文
共 47 条
  • [31] Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors
    Dansinger, Michael L.
    Williams, Paul T.
    Superko, H. Robert
    Schaefer, Ernst J.
    LIPIDS IN HEALTH AND DISEASE, 2019, 18 (1)
  • [32] Omega-3 Fatty Acids and Cardiovascular Disease Effects on Risk Factors, Molecular Pathways, and Clinical Events
    Mozaffarian, Dariush
    Wu, Jason H. Y.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : 2047 - 2067
  • [33] Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome—LIPGENE: a European randomized dietary intervention study
    A C Tierney
    J McMonagle
    D I Shaw
    H L Gulseth
    O Helal
    W H M Saris
    J A Paniagua
    I Gołąbek-Leszczyñska
    C Defoort
    C M Williams
    B Karsltröm
    B Vessby
    A Dembinska-Kiec
    J López-Miranda
    E E Blaak
    C A Drevon
    M J Gibney
    J A Lovegrove
    H M Roche
    International Journal of Obesity, 2011, 35 : 800 - 809
  • [34] Short term effects of energy restriction and dietary fat sub-type on weight loss and disease risk factors
    Tapsell, L.
    Batterham, M.
    Huang, X. F.
    Tan, S. -Y.
    Teuss, G.
    Charlton, K.
    OShea, J.
    Warensjoe, E.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2010, 20 (05) : 317 - 325
  • [35] Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome-LIPGENE: a European randomized dietary intervention study
    Tierney, A. C.
    McMonagle, J.
    Shaw, D. I.
    Gulseth, H. L.
    Helal, O.
    Saris, W. H. M.
    Paniagua, J. A.
    Golabek-Leszczynska, I.
    Defoort, C.
    Williams, C. M.
    Karsltrom, B.
    Vessby, B.
    Dembinska-Kiec, A.
    Lopez-Miranda, J.
    Blaak, E. E.
    Drevon, C. A.
    Gibney, M. J.
    Lovegrove, J. A.
    Roche, H. M.
    INTERNATIONAL JOURNAL OF OBESITY, 2011, 35 (06) : 800 - 809
  • [36] Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome
    Mohammadi, Elahe
    Rafraf, Maryam
    Farzadi, Laya
    Asghari-Jafarabadi, Mohammad
    Sabour, Siamak
    ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION, 2012, 21 (04) : 511 - 518
  • [37] Baseline levels of serum high sensitivity C reactive protein and lipids in predicting the residual risk of cardiovascular events in Chinese population with stable coronary artery disease: a prospective cohort study
    Dai, Wen
    Zhang, Ziyu
    Zhao, Shuiping
    LIPIDS IN HEALTH AND DISEASE, 2018, 17
  • [38] Validation of a model to investigate the effects of modifying cardiovascular disease (CVD) risk factors on the burden of CVD: the rotterdam ischemic heart disease and stroke computer simulation (RISC) model
    van Kempen, Bob J. H.
    Ferket, Bart S.
    Hofman, Albert
    Steyerberg, Ewout W.
    Colkesen, Ersen B.
    Boekholdt, S. Matthijs
    Wareham, Nicholas J.
    Khaw, Kay-Tee
    Hunink, M. G. Myriam
    BMC MEDICINE, 2012, 10
  • [39] Validation of a model to investigate the effects of modifying cardiovascular disease (CVD) risk factors on the burden of CVD: the rotterdam ischemic heart disease and stroke computer simulation (RISC) model
    Bob JH van Kempen
    Bart S Ferket
    Albert Hofman
    Ewout W Steyerberg
    Ersen B Colkesen
    S Matthijs Boekholdt
    Nicholas J Wareham
    Kay-Tee Khaw
    MG Myriam Hunink
    BMC Medicine, 10
  • [40] Altered serum levels of FGF-23 and magnesium are independent risk factors for an increased albumin-to-creatinine ratio in type 2 diabetics with chronic kidney disease
    Silva, Ana Paula
    Mendes, Filipa
    Fragoso, Andre
    Jeronimo, Teresa
    Pimentel, Ana
    Gundlach, Kristina
    Buechel, Janine
    Santos, Nelio
    Neves, Pedro Leao
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (02) : 275 - 280